Alloferon Alleviates Dextran Sulfate Sodium-induced Colitis |
Kim, Hyemin
(Department of Anatomy, Seoul National University College of Medicine)
Im, Jong Pil (Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine) Kim, Joo Sung (Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine) Kang, Jae Seung (Department of Anatomy, Seoul National University College of Medicine) Lee, Wang Jae (Department of Anatomy, Seoul National University College of Medicine) |
1 | Xavier, R. J., and D. K. Podolsky. 2007. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448: 427-434. DOI |
2 | Baumgart, D. C., and W. J. Sandborn. 2007. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 369: 1641-1657. DOI |
3 | Thia, K. T., E. V. Loftus, Jr., W. J. Sandborn, and S. K. Yang. 2008. An update on the epidemiology of inflammatory bowel disease in Asia. Am. J .Gastroenterol. 103: 3167-3182. DOI |
4 | Yang, S. K., S. Yun, J. H. Kim, J. Y. Park, H. Y. Kim, Y. H. Kim, D. K. Chang, J. S. Kim, I. S. Song, J. B. Park, E. R. Park, K. J. Kim, G. Moon, and S. H. Yang. 2008. Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID study. Inflamm. Bowel. Dis. 14: 542-549. DOI |
5 | Chernysh, S., K. Irina, and A. Irina. 2012. Anti-tumor activity of immunomodulatory peptide alloferon-1 in mouse tumor transplantation model. Int. Immunopharmacol. 12: 312-314. DOI |
6 | Lee, N., S. Bae, H. Kim, J. M. Kong, H. R. Kim, B. J. Cho, S. J. Kim, S. H. Seok, Y. I. Hwang, S. Kim, J. S. Kang, and W. J. Lee. 2011. Inhibition of lytic reactivation of Kaposi's sarcoma- associated herpesvirus by alloferon. Antivir. Ther. 16: 17-26. DOI |
7 | Bae, S., K. Oh, H. Kim, Y. Kim, H. R. Kim, Y. I. Hwang, D. S. Lee, J. S. Kang, and W. J. Lee. 2013. The effect of alloferon on the enhancement of NK cell cytotoxicity against cancer via the up-regulation of perforin/granzyme B secretion. Immunobiology 218: 1026-1033. DOI |
8 | Kim, Y., S. K. Lee, S. Bae, H. Kim, Y. Park, N. K. Chu, S. G. Kim, H. R. Kim, Y. I. Hwang, J. S. Kang, and W. J. Lee. 2013. The anti-inflammatory effect of alloferon on UVB-induced skin inflammation through the down-regulation of pro-inflammatory cytokines. Immunol. Lett. 149: 110-118. DOI |
9 | Sander, L. E., F. Obermeier, U. Dierssen, D. C. Kroy, A. K. Singh, U. Seidler, K. L. Streetz, H. H. Lutz, W. Muller, F. Tacke, and C. Trautwein. 2008. Gp130 signaling promotes development of acute experimental colitis by facilitating early neutrophil/macrophage recruitment and activation. J. Immunol. 181: 3586-3594. DOI |
10 | Lin, Y., X. Yang, W. Yue, X. Xu, B. Li, L. Zou, and R. He. 2014. Chemerin aggravates DSS-induced colitis by suppressing M2 macrophage polarization. Cell. Mol. Immunol. 11: 355-366. DOI |
11 | Li, B., R. Alli, P. Vogel, and T. L. Geiger. 2014. IL-10 modulates DSS-induced colitis through a macrophage-ROS-NO axis. Mucosal Immunol. 7: 869-878. DOI |
12 | Jarry, A., C. Bossard, C. Bou-Hanna, D. Masson, E. Espaze, M. G. Denis, and C. L. Laboisse. 2008. Mucosal IL-10 and TGF-beta play crucial roles in preventing LPS-driven, IFN-gamma-mediated epithelial damage in human colon explants. J. Clin. Invest. 118: 1132-1142. |
13 | Marrero, J. A., K. A. Matkowskyj, K. Yung, G. Hecht, and R. V. Benya. 2000. Dextran sulfate sodium-induced murine colitis activates NF-kappaB and increases galanin-1 receptor expression. Am. J. Physiol. Gastrointest. Liver Physiol. 278: G797-G804. DOI |
14 | Andresen, L., V. L. Jorgensen, A. Perner, A. Hansen, J. Eugen-Olsen, and J. Rask-Madsen. 2005. Activation of nuclear factor kappaB in colonic mucosa from patients with collagenous and ulcerative colitis. Gut 54: 503-509. DOI |
15 | Rogler, G., K. Brand, D. Vogl, S. Page, R. Hofmeister, T. Andus, R. Knuechel, P. A. Baeuerle, J. Scholmerich, and V. Gross. 1998. Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology 115: 357-369. DOI |
16 | Kanarek, N., N. London, O. Schueler-Furman, and Y. Ben-Neriah. 2010. Ubiquitination and degradation of the inhibitors of NFkappaB. Cold Spring Harb. Perspect. Biol. 2: a000166. |
17 | Chernysh, S., and N. Gordja. 2011. The immune system of maggots of the blow fly (Calliphora vicina) as a source of medicinal drugs. J. Evol. Biochem. Physiol. 47: 524-533. DOI |
18 | Hanauer, S. B. 2006. Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm. Bowel. Dis. 12 Suppl 1: S3-S9. |
19 | Molodecky, N. A., I. S. Soon, D. M. Rabi, W. A. Ghali, M. Ferris, G. Chernoff, E. I. Benchimol, R. Panaccione, S. Ghosh, H. W. Barkema, and G. G. Kaplan. 2012. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142: 46-54. DOI |
20 | Ershov, F., A. Kubanova, B. Pinegin, A. Shulzhenko, G. Bekker, and S. Chernysh. 2003. Allokine- effect on the course of chronic genital herpes relapses. Materia Medica 40: 103-111. |
21 | Taylor, B. S., M. E. de Vera, R. W. Ganster, Q. Wang, R. A. Shapiro, S. M. Morris, Jr., T. R. Billiar, and D. A. Geller. 1998. Multiple NF-kappaB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthase gene. J. Biol. Chem. 273: 15148-15156. DOI |
22 | Neurath, M. F., S. Finotto, I. Fuss, M. Boirivant, P. R. Galle, and W. Strober. 2001. Regulation of T-cell apoptosis in inflammatory bowel disease: to die or not to die, that is the mucosal question. Trends Immunol. 22: 21-26. DOI |
23 | Grivennikov, S., E. Karin, J. Terzic, D. Mucida, G. Y. Yu, S. Vallabhapurapu, J. Scheller, S. Rose-John, H. Cheroutre, L. Eckmann, and M. Karin. 2009. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 15: 103-113. DOI |
24 | Jin, X., T. A. Zimmers, Z. Zhang, R. H. Pierce, and L. G. Koniaris. 2010. Interleukin-6 is an important in vivo inhibitor of intestinal epithelial cell death in mice. Gut 59: 186-196. DOI |
25 | Kraus, T. A., L. Toy, L. Chan, J. Childs, A. Cheifetz, and L. Mayer. 2004. Failure to induce oral tolerance in Crohn's and ulcerative colitis patients: possible genetic risk. Ann. N. Y. Acad. Sci. 1029: 225-238. DOI |
26 | Lee, M. J., J. K. Lee, J. W. Choi, C. S. Lee, J. H. Sim, C. H. Cho, K. H. Lee, I. H. Cho, M. H. Chung, H. R. Kim, and S. K. Ye. 2012. Interleukin-6 induces S100A9 expression in colonic epithelial cells through STAT3 activation in experimental ulcerative colitis. PLoS One 7: e38801. DOI |
27 | Chernysh, S., S. I. Kim, G. Bekker, V. A. Pleskach, N. A. Filatova, V. B. Anikin, V. G. Platonov, and P. Bulet. 2002. Antiviral and antitumor peptides from insects. Proc. Natl. Acad. Sci. U. S. A. 99: 12628-12632. DOI |
28 | Triantafillidis, J. K., G. Nasioulas, and P. A. Kosmidis. 2009. Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies. Anticancer Res. 29: 2727-2737. |
29 | Ryu, M. J., V. Anikin, S. H. Hong, H. Jeon, Y. G. Yu, M. H. Yu, S. Chernysh, and C. Lee. 2008. Activation of NF-kappaB by alloferon through down-regulation of antioxidant proteins and IkappaBalpha. Mol. Cell. Biochem. 313: 91-102. DOI |
30 | Cheng, M., Y. Chen, W. Xiao, R. Sun, and Z. Tian. 2013. NK cell-based immunotherapy for malignant diseases. Cell. Mol.Immunol. 10: 230-252. DOI |
31 | Chandel, N. S., W. C. Trzyna, D. S. McClintock, and P. T. Schumacker. 2000. Role of oxidants in NF-kappa B activation and TNF-alpha gene transcription induced by hypoxia and endotoxin. J. Immunol. 165: 1013-1021. DOI |